Assertio Holdings (ASRT) Return on Capital Employed Growth (1y) (2021 - 2026)
Assertio Holdings (ASRT) Return on Capital Employed Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 696.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -494.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 89.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 448.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1,397.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -1,715.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2,309.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 999.00 |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | 314.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 314.00 |
| Dec 31, 2025 | 179.00 |
| Sep 30, 2025 | 520.00 |
| Jun 30, 2025 | 11,685.00 |
| Mar 31, 2025 | 11,040.00 |
| Dec 31, 2024 | 8,679.00 |
| Sep 30, 2024 | 4,898.00 |
| Jun 30, 2024 | -15,279.00 |
| Mar 31, 2024 | -14,186.00 |
| Dec 31, 2023 | -11,598.00 |
| Sep 30, 2023 | -8,803.00 |
| Jun 30, 2023 | -658.00 |
| Mar 31, 2023 | 323.00 |
| Dec 31, 2022 | 912.00 |
| Sep 30, 2022 | 3,139.00 |
| Jun 30, 2022 | 3,885.00 |
| Mar 31, 2022 | 3,520.00 |
| Dec 31, 2021 | 4,962.00 |
| Sep 30, 2021 | 10,004.00 |